UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 27, 2021
Accession Number:
0001193125-21-017696
Submission Type:
POS AM
CIK:
0001731831
Company Name:
Eidos Therapeutics, Inc.
File Number:
333-232999